#1 Startup Dataset
Growth rates, revenue data, direct competitors and contact details.
Nilomi Shah Email
Director, Medical Affairs Lead . Lexeo Therapeutics
New York, NY
LocationPrimary Email
How to contact Nilomi Shah
Join and see Nilomi's contact info for free!Phone
Current Roles
Employees:
79Revenue:
$12.2MAbout
LEXEO Therapeutics is a New York City-based, fully integrated biotechnology company currently headquartered at the Alexandria Center® for Life Science that aims to apply the transformational science of gene therapy to address some of the world's most devastating genetic and acquired diseases. LEXEO Therapeutics' pipeline consists of adeno-associated virus (AAV)-mediated therapies primarily developed at Weill Cornell Medicine's Department of Genetic Medicine. Beyond LEXEO Therapeutics' lead programs – which are focused on both rare and non-rare monogenic (single gene mutation) diseases – the company's preclinical pipeline spans monogenic diseases, as well as hereditary and acquired diseases across a spectrum of patient population sizes and a range of unmet medical needs. Importantly, LEXEO Therapeutics will focus on advancing clinical programs through to commercialization, with the goal of maintaining an ongoing research collaboration with Weill Cornell Medicine's Department of Genetic Medicine to help advance the company's pre-clinical pipeline. For more information, please visit www.lexeotx.com.Lexeo Therapeutics Address
345 Park Avenue SouthNew York, NY
United States